Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$4.54 - $9.89 $9,770 - $21,283
-2,152 Reduced 30.56%
4,890 $25,000
Q1 2024

May 15, 2024

SELL
$4.03 - $8.13 $21,084 - $42,536
-5,232 Reduced 42.63%
7,042 $57,000
Q4 2023

Feb 14, 2024

BUY
$3.56 - $4.65 $5,770 - $7,537
1,621 Added 15.22%
12,274 $49,000
Q3 2023

Nov 14, 2023

SELL
$4.02 - $5.81 $23,902 - $34,546
-5,946 Reduced 35.82%
10,653 $43,000
Q2 2023

Aug 14, 2023

SELL
$3.06 - $6.38 $11,551 - $24,084
-3,775 Reduced 18.53%
16,599 $98,000
Q1 2023

May 15, 2023

BUY
$3.22 - $4.72 $27,849 - $40,823
8,649 Added 73.77%
20,374 $70,000
Q4 2022

Feb 14, 2023

BUY
$3.03 - $3.79 $35,526 - $44,437
11,725 New
11,725 $41,000
Q2 2022

Aug 15, 2022

BUY
$5.13 - $9.2 $203,224 - $364,458
39,615 Added 95.99%
80,884 $455,000
Q1 2022

May 16, 2022

SELL
$8.64 - $11.71 $56,669 - $76,805
-6,559 Reduced 13.71%
41,269 $356,000
Q3 2021

Nov 15, 2021

BUY
$12.95 - $18.24 $470,874 - $663,224
36,361 Added 317.09%
47,828 $619,000
Q3 2020

Nov 16, 2020

BUY
$13.97 - $21.16 $160,193 - $242,641
11,467 New
11,467 $219,000
Q2 2020

Aug 14, 2020

SELL
$10.39 - $16.07 $354,652 - $548,533
-34,134 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$8.89 - $24.94 $132,523 - $371,780
14,907 Added 77.53%
34,134 $363,000
Q2 2019

Aug 14, 2019

BUY
$6.99 - $11.27 $134,396 - $216,688
19,227 New
19,227 $146,000

Others Institutions Holding XBIT

About XBiotech Inc.


  • Ticker XBIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,439,300
  • Market Cap $203M
  • Description
  • XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...
More about XBIT
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.